Oxford Global’s 17th Annual Drug Discovery Leaders Summit and our co-located 4th Annual Discovery 91AV and Drug Design Congress is Europe’s leading Summit in the drug discovery and discovery chemistry field. Our prestigious Summit brings together prominent decision makers working at the forefront of research into target based discovery, phenotypic screening, medicinal chemistry and drug design.
Our Summit will consist of 7 interactive streams covering:
Target Based Discovery
Screening and Assays: Enabling Technologies
Novel Therapeutic Modalities and New Target Classes
Supporting Innovation: Data and Information Management
Discovery 91AV: Latest Case Studies
Drug Design: Novel Approaches
Large Molecule Discovery Approaches
On day one our panel of discovery experts will explore the resurgence of phenotypic screening, the latest innovations in high content analysis and the most promising new therapeutic modalities such as the microbiome, natural products and new target classes. Day one also features a stream dedicated to the latest research in medicinal chemistry, including exciting protein-protein interaction updates.
On day two delegates will hear from our industry leaders about the most promising new large molecule discovery techniques, and our data and information management stream will host exciting discussions about how to exploit Big Data for more efficient drug discovery and our third stream is dedicated to the most innovative approaches to drug design.
Our Summit will consist of 7 interactive streams covering:
Target Based Discovery
Screening and Assays: Enabling Technologies
Novel Therapeutic Modalities and New Target Classes
Supporting Innovation: Data and Information Management
Discovery 91AV: Latest Case Studies
Drug Design: Novel Approaches
Large Molecule Discovery Approaches
On day one our panel of discovery experts will explore the resurgence of phenotypic screening, the latest innovations in high content analysis and the most promising new therapeutic modalities such as the microbiome, natural products and new target classes. Day one also features a stream dedicated to the latest research in medicinal chemistry, including exciting protein-protein interaction updates.
On day two delegates will hear from our industry leaders about the most promising new large molecule discovery techniques, and our data and information management stream will host exciting discussions about how to exploit Big Data for more efficient drug discovery and our third stream is dedicated to the most innovative approaches to drug design.
